[Therapy of heart failure with reduced pump function]. / Therapie der Herzinsuffizienz mit reduzierter Pumpfunktion.
Dtsch Med Wochenschr
; 149(4): 157-165, 2024 Feb.
Article
en De
| MEDLINE
| ID: mdl-38286146
ABSTRACT
HFrEF causes significant morbidity and mortality and represents a major public health burden. Recently, there have been significant scientific advances in the treatment of HFrEF, with ARNI, BB, MRA, and SGLT-2i forming the GDMT for HFrEF. Basic quadruple therapy has been shown to significantly reduce of HF hospitalizations, all-cause mortality, and cardiovascular mortality. In addition, new initiation and titration procedures have recently been introduced that may progressively improve the management and prognosis of HFrEF. Further efforts are also needed to improve the use of GDMT, which is currently underutilized.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Cardíaca
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
De
Revista:
Dtsch Med Wochenschr
Año:
2024
Tipo del documento:
Article